Department of Pulmonary and Critical Care Medicine (PCCM)

The Department of Pulmonary and Critical Care Medicine (PCCM) relies on science and technology and academic pursuits for development. The department has gradually grown and has now become a comprehensive respiratory disease diagnosis and treatment department integrating medical care, teaching, and scientific research. In recent years, it has accumulated extensive experience in the diagnosis and treatment of common respiratory diseases such as chronic obstructive pulmonary disease, respiratory failure, pulmonary infections, bronchial asthma, and lung cancer, while also demonstrating its own distinctive strengths. The diagnosis and treatment of interstitial lung diseases have become a major specialty of the Department of Pulmonary Medicine. The department is a clinical drug trial base of the National Medical Products Administration and a master's student training site of Nanjing Medical University. It has undertaken numerous research projects of the Ministry of Health, Zhejiang Province, and other institutions, and has hosted the Zhejiang Province continuing education program on interstitial lung diseases for two consecutive years. The Department of Pulmonary Medicine has 13 physicians, including 5 with doctoral degrees, 5 with master's degrees, and 3 with bachelor's degrees, as well as 17 nurses, including 2 associate chief nurses and 4 nurses-in-charge. The discipline leader, Wang Limin, is a master's supervisor, chairperson of the Respiratory Branch of the Hangzhou Medical Association, a committee member of the Respiratory Branch of the Zhejiang Medical Association, and a committee member of the Respiratory Branch of the Zhejiang Medical Doctors Association. The Department of Pulmonary Medicine is a national drug clinical trial base, a national GINA-ARIA physician training base, a Class II key discipline designated by the Hangzhou Municipal Health and Family Planning Commission, the Hangzhou Lung Cancer Diagnosis and Treatment Center, and a master's training site of Nanjing Medical University. It leads 46 community hospitals in the main urban area of Hangzhou in the standardized management and treatment of bronchial asthma and chronic obstructive pulmonary disease; it advocates comprehensive clinical-pathological-imaging diagnosis of interstitial lung diseases, enabling many difficult and rare diseases to be diagnosed and treated in a timely manner and earning praise from patients. The Department of Pulmonary Medicine also undertakes multiple teaching tasks, including theoretical teaching, clinical internships, and training for master's graduate students, seven-year-program medical students, five-year-program medical students, and visiting physicians of Nanjing Medical University. Its excellent professional ethics, outstanding medical expertise, and exceptional teaching standards have won unanimous praise from the trainees.